JP6479799B2 - 粒子への分子の接合 - Google Patents

粒子への分子の接合 Download PDF

Info

Publication number
JP6479799B2
JP6479799B2 JP2016533754A JP2016533754A JP6479799B2 JP 6479799 B2 JP6479799 B2 JP 6479799B2 JP 2016533754 A JP2016533754 A JP 2016533754A JP 2016533754 A JP2016533754 A JP 2016533754A JP 6479799 B2 JP6479799 B2 JP 6479799B2
Authority
JP
Japan
Prior art keywords
particles
particle
molecules
nanoparticles
transition metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016533754A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016534342A (ja
JP2016534342A5 (enExample
Inventor
マエジ，ノブヨシ，ジョー
ホワン，チャンイー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anteo Technologies Pty Ltd
Original Assignee
Anteo Technologies Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903093A external-priority patent/AU2013903093A0/en
Application filed by Anteo Technologies Pty Ltd filed Critical Anteo Technologies Pty Ltd
Publication of JP2016534342A publication Critical patent/JP2016534342A/ja
Publication of JP2016534342A5 publication Critical patent/JP2016534342A5/ja
Application granted granted Critical
Publication of JP6479799B2 publication Critical patent/JP6479799B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP2016533754A 2013-08-13 2014-08-13 粒子への分子の接合 Active JP6479799B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2013903093 2013-08-13
AU2013903093A AU2013903093A0 (en) 2013-08-13 Conjugating molecules to particles
PCT/AU2014/050181 WO2015021509A1 (en) 2013-08-13 2014-08-13 Conjugating molecules to particles

Publications (3)

Publication Number Publication Date
JP2016534342A JP2016534342A (ja) 2016-11-04
JP2016534342A5 JP2016534342A5 (enExample) 2017-09-21
JP6479799B2 true JP6479799B2 (ja) 2019-03-06

Family

ID=52467859

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016533754A Active JP6479799B2 (ja) 2013-08-13 2014-08-13 粒子への分子の接合

Country Status (6)

Country Link
US (2) US11726095B2 (enExample)
EP (1) EP3033360B1 (enExample)
JP (1) JP6479799B2 (enExample)
CN (1) CN105452299A (enExample)
AU (1) AU2014306363B2 (enExample)
WO (1) WO2015021509A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3157938B1 (en) * 2014-06-17 2022-03-16 Anteo Technologies Pty Ltd. Hetero functional binding systems
EP3337527B1 (en) * 2015-08-20 2020-09-23 Anteo Technologies Pty Ltd. Functional coating
US11202835B2 (en) 2015-11-20 2021-12-21 Anteo Technologies Pty Ltd Method of controlled competitive exchange
US11867699B2 (en) 2016-06-10 2024-01-09 The University Of Queensland Detecting an analyte
JP6859215B2 (ja) * 2017-04-17 2021-04-14 日本光電工業株式会社 脂質二重膜粒子またはその断片の検出方法
CN108623606B (zh) * 2018-08-02 2019-11-12 杭州中美华东制药有限公司 一种依鲁替尼的合成方法
CN109276720B (zh) * 2018-09-19 2020-10-30 浙江大学 一种金属-有机物配合物纳米材料及其制备方法和应用
GB201912866D0 (en) * 2019-09-06 2019-10-23 Cambridge Molecular Diagnostics Ltd Miltiply labelled polymetric molecule for detection assays
CN115697906A (zh) * 2020-04-08 2023-02-03 安泰奥能源科技有限公司 复合颗粒及其形成方法
CN111856016B (zh) * 2020-07-29 2023-08-01 武汉生之源生物科技股份有限公司 一种涎液化糖链抗原测定试剂盒及其制备方法
WO2023056529A1 (en) * 2021-10-08 2023-04-13 Anteo Technologies Pty Ltd Binding support and uses thereof
WO2023056528A1 (en) * 2021-10-08 2023-04-13 Anteo Technologies Pty Ltd Lateral flow assay
CN118986895B (zh) * 2024-07-31 2025-10-24 山东第一医科大学附属眼科医院(山东省眼科医院) 一种可见光催化交联的病毒样氧化钌纳米颗粒用于高效跨膜治疗圆锥角膜

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05502944A (ja) 1989-12-22 1993-05-20 モレキュラ　バイオクエスト　インコーポレイテッド 分離に使用するための有機金属で被覆された粒子
DE59507438D1 (de) * 1994-07-25 2000-01-20 Roche Diagnostics Gmbh Hydrophile metallkomplexe
TWI242645B (en) 2002-10-15 2005-11-01 Ind Tech Res Inst Biochemical labeling materials and manufacturing method
CN1852765A (zh) * 2002-10-18 2006-10-25 普罗梅加公司 用于分离分子的组合物
CN101421623A (zh) * 2003-12-22 2009-04-29 爱默蕾大学 生物共轭的纳米结构、其制造方法、和其使用方法
US7846412B2 (en) * 2003-12-22 2010-12-07 Emory University Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof
US8168445B2 (en) * 2004-07-02 2012-05-01 Bio-Layer Pty Limited Use of metal complexes
WO2009139939A2 (en) * 2008-02-22 2009-11-19 The University Of North Carolina At Chapel Hill Hybrid nanoparticles as anti-cancer therapeutic agents and dual therapeutic/imaging contrast agents
US10525152B2 (en) * 2009-10-09 2020-01-07 Signablok, Inc. Methods and compositions for targeted imaging
WO2011046842A1 (en) 2009-10-12 2011-04-21 The Regents Of The University Of California Targeted nanoclusters and methods of their use
JP5885266B2 (ja) * 2010-05-10 2016-03-15 アンテオ テクノロジーズ プロプライエタリー リミテッドＡｎｔｅｏ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｐｔｙ Ｌｔｄ 結合系
BR112013001642A8 (pt) * 2010-07-23 2016-10-11 Luminex Corp coacoplamento para controlar a reatividade de reagentes em imunoensaios
EP3157938B1 (en) * 2014-06-17 2022-03-16 Anteo Technologies Pty Ltd. Hetero functional binding systems
EP3337527B1 (en) * 2015-08-20 2020-09-23 Anteo Technologies Pty Ltd. Functional coating

Also Published As

Publication number Publication date
JP2016534342A (ja) 2016-11-04
US20240053348A1 (en) 2024-02-15
US20160178636A1 (en) 2016-06-23
AU2014306363B2 (en) 2019-05-02
EP3033360A1 (en) 2016-06-22
CN105452299A (zh) 2016-03-30
EP3033360B1 (en) 2019-11-27
EP3033360A4 (en) 2017-04-12
US11726095B2 (en) 2023-08-15
WO2015021509A1 (en) 2015-02-19
AU2014306363A1 (en) 2016-02-18

Similar Documents

Publication Publication Date Title
JP6479799B2 (ja) 粒子への分子の接合
US10191042B2 (en) Core-shell nanoparticles with multiple cores and method for fabricating them
Gao et al. A dual signal amplification method for exosome detection based on DNA dendrimer self-assembly
Cui et al. Synthesis of orientedly bioconjugated core/shell Fe3O4@ Au magnetic nanoparticles for cell separation
CN104011545B (zh) 利用两种粒子的多功能生物材料接合体的制备方法及从中制得的多功能生物材料接合体
CN103743722B (zh) 一种基于纳米颗粒和化学发光的核酸适体传感器及制备方法和应用
CN104031201B (zh) 一种用于生物蛋白分离的磁性微球的制备方法及其应用
CN102559170B (zh) 一种鲁米诺发光功能化的纳米银及其制备方法和应用
CN101977711B (zh) 被覆金属微粒及其制造方法
CN107446916B (zh) 一种用于纯化并定向固定化组氨酸标签蛋白的方法和应用
JP2012529644A (ja) シグナル増幅マイクロスフェア、単ステップ及びマルチステップ分析増幅手順におけるそれらの使用並びにそれらの製造方法
Smith et al. Optimization of antibody-conjugated magnetic nanoparticles for target preconcentration and immunoassays
JP2011505580A (ja) バイオプローブと、その製造方法、それを利用した分析装置及び分析方法
CN110346560B (zh) 一种多酶信号颗粒及其制备方法与应用
CN105366730B (zh) 一种使用dna纳米结构对疏水性纳米粒子相转换的方法
CN104437440A (zh) 一种多氨基硅包磁性纳米粒子的制备与应用
JPWO2003066644A1 (ja) フェライト結合有機物質及びその製造方法
CN113355388B (zh) 一种基于核酸外切酶ⅲ辅助信号放大的免疫吸附检测氯霉素的方法
Roque et al. Antibody immobilization on magnetic particles
CN114459877B (zh) 用于富集外泌体的dna四面体复合磁性纳米材料及制备
CN114989823B (zh) 一种疏水量子点纳米材料、纳米探针及其制备方法和应用
Jeevanandam et al. Biofunctional nanoparticles for protein separation, purification and detection
JP4136715B2 (ja) タンパク質固定化磁性担体およびその製造方法、ならびにその利用
US7332352B2 (en) Separation particles
JP2005538714A (ja) 磁気的に誘導された膜輸送のための粒子

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170809

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170809

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180418

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180605

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180821

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190129

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190206

R150 Certificate of patent or registration of utility model

Ref document number: 6479799

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250